Prot#4130-CL-0201: A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination with mFOLFOX6 with Bevacizumab in Combination with mFOLFOX6 in Stage IV Metastatic Colorectal Cancer (mCRC) Subjects

Project: Research project

Project Details

StatusFinished
Effective start/end date4/12/124/12/15

Funding

  • Astellas Pharma Global Development, Inc. (4130-CL-0201)